Torsten Rotto
Sports Medicine · Zanesville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Genesis Medical Group, LLC · 265 clinicians in this group
Looking this up.
Hospitals listed: Genesis Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Torsten Rotto’s office at (740) 586-6828 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Genesis HospitalZanesville, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Genesis Healthcare SystemPatients rate it 4 of 5 · 71% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.148, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.71, Oct 2024 – Sep 2025
See every measure and the patient survey for Genesis Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 7 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.148 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.71 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.31 to 2.24) · 972 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.8 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 157.52 (106.87 to 208.18) · 78 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 156 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.4 · 497 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 556 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.7 · 264 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 3,528 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.38) · 6,182 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 6,317 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.15 (2.05 to 6.24) · 1,442 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.03 (0.53 to 3.54) · 487 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.82 (1.37 to 4.28) · 1,323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.73 (2.88 to 16.59) · 487 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.78 (4.17 to 11.39) · 473 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.07) · 208 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0 to 1.19) · 4,767 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 55 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.223 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.259 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.7 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.2 · 434 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.2 · 860 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -19.6 · 253 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 537 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 598 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 927 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.4 to 7) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.9 (7.6 to 12.8) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.8 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.9 to 16.9) · 2,463 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 607 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,810 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Medicaid work
$13,516 in 2023
Medicaid paid $13,516 for 123 billed services this clinician did in 2023, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 56 | $13,516 |
| Short return visit (20+ min) | 67 | $0 |
| 2023 | 123 | 2 | 20 | $13,516 |
| 2022 | 28 | 1 | 15 | $6,758 |
See the largest Medicaid services in earlier years
2022
| Clinic visit/encounter, all-inclusive | 28 | $6,758 |
Drugs they prescribed that Part D paid
$37,981
Pharmacies billed $37,981 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (13 of 397) in 2024. Above the middle of the specialty; the typical family medicine clinician is at 0%.
357 generic and 40 brand-name prescriptions · $37,981 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine-Naloxone | 14 | $1,239 | $88 |
| Amlodipine Besylate | 42 | $237 | $6 |
| Atorvastatin | 32 | $194 | $6 |
| Diclofenac | 14 | $145 | $10 |
| Omeprazole | 11 | $105 | $10 |
See all 7 drugs
| Buprenorphine-Naloxone | 14 | $1,239 | $88 |
| Amlodipine Besylate | 42 | $237 | $6 |
| Atorvastatin | 32 | $194 | $6 |
| Diclofenac | 14 | $145 | $10 |
| Omeprazole | 11 | $105 | $10 |
| Losartan | 15 | $87 | $6 |
| Metformin | 15 | $75 | $5 |
Year by year
| 2024 | 397 | 69 | 3% (13) | 10% | $37,981 |
| 2023 | 561 | 116 | 5% (26) | 12% | $63,071 |
| 2022 | 260 | 66 | 6% (16) | None | $34,938 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Ozempic | 11 | $10,970 | $997 |
| Buprenorphine-Naloxone | 12 | $1,617 | $135 |
| Zolpidem | 11 | $1,362 | $124 |
| Amlodipine Besylate | 45 | $1,332 | $30 |
| Tamsulosin | 11 | $1,013 | $92 |
| Diclofenac | 31 | $938 | $30 |
| Atorvastatin | 43 | $907 | $21 |
| Levothyroxine | 18 | $447 | $25 |
| Metoprolol | 12 | $398 | $33 |
| Losartan | 20 | $371 | $19 |
| Metoprolol | 11 | $304 | $28 |
| Tramadol | 11 | $279 | $25 |
| Metformin | 25 | $162 | $6 |
| Hydrocodone-Acetaminophen | 11 | $96 | $9 |
2022: 4 drugs
| Atorvastatin | 25 | $352 | $14 |
| Amlodipine Besylate | 24 | $326 | $14 |
| Metformin | 16 | $212 | $13 |
| Losartan | 14 | $105 | $8 |
Professional record
- NPI
- 1932787538
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2083S0010X (2083S0010X); Family medicine (207Q00000X); Federal specialty code 207QS0010X (207QS0010X)
- Mailing address
- Po Box 5074, Sioux Falls, SD, 57117
- NPI first listed
- 2021-04-02
- NPI last updated
- 2026-08-13
- NPI record certified
- 2026-08-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 455 O'Connor Drive Indian Health Center - Fmc, San Jose, CA, 95128